Vote Scores

Home / Companies / Immunovant, Inc. / 27 Aug 2025

Meeting · year to 30 June 2026265 filers reporting

Immunovant, Inc.: meeting of 27 Aug 2025

Votes reported on Form N-PX, item by item

265 Form N-PX filers reported votes at the Immunovant, Inc. meeting of 27 Aug 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 73.8% of reported votes for; 62 filers withheld from or voted against at least one nominee.

522 vote records from 93 filers. 5 of the 93 filers that marked the item either way voted against management.

94.6% for0.0% against5.4% other5.4% against management93 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

394 vote records from 264 filers. 14 of the 253 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.

90.2% for5.3% against4.5% other5.5% against management264 filers99.7% for0.2% against0.1% other0.2% against management85,401,847 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

174 vote records from 93 filers. 0 of the 93 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management93 filers100.0% for0.0% against0.0% other0.0% against management26,093,029 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyNo reportForNo report
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialNo reportForNo report
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustNo reportForNo report
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalForForFor
Pacific Life fundsForForFor
Global XForForFor
AllianceBernsteinNo reportForNo report
DWSForForFor
MassMutualForForFor
Macquarie and Delaware FundsAbstain or withhold *ForFor
Neuberger BermanNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Immunovant, Inc. meeting?

265 Form N-PX filers reported votes at the meeting of 27 Aug 2025. On say-on-pay, 14 of 253 voted against management (5.5%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Immunovant, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Immunovant, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Immunovant, Inc. with a meeting date within three days of 27 Aug 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.